- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Ligand Pharmaceuticals (NASDAQ:LGND), Quotes and News Summary
Ligand Pharmaceuticals (NASDAQ: LGND)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-07-28 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.660 | 0.760 | 0.1000 | ||||
| REV | 34.210M | 45.693M | 11.483M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Ligand Pharmaceuticals Questions & Answers
You can purchase shares of Ligand Pharmaceuticals (NASDAQ: LGND) through any online brokerage.
Other companies in Ligand Pharmaceuticals’s space includes: Valneva (NASDAQ:VALN), Zentalis Pharmaceuticals (NASDAQ:ZNTL), Prothena Corp (NASDAQ:PRTA), Day One Biopharmaceutical (NASDAQ:DAWN) and Xencor (NASDAQ:XNCR).
The latest price target for Ligand Pharmaceuticals (NASDAQ: LGND) was reported by Barclays on Tuesday, July 5, 2022. The analyst firm set a price target for 157.00 expecting LGND to rise to within 12 months (a possible 63.83% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Ligand Pharmaceuticals (NASDAQ: LGND) is $95.83 last updated Today at July 6, 2022, 8:00 PM UTC.
A quarterly cash dividend of $2.50 per share of Class A Common Stock. The quarterly cash dividend was payable on April 19, 2007 to stockholders of record on April 3, 2007.
Ligand Pharmaceuticals’s Q2 earnings are confirmed for Thursday, July 28, 2022.
There is no upcoming split for Ligand Pharmaceuticals.
Ligand Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.